logo

For the Inventor, By the Inventor

Gujarat, India

Shriprakash Dhar Dwivedi

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Ahmedabad, IN (2012 - 2016)
  • Gujarah, IN (2017)
  • Gujarat, IN (2014 - 2019)

Company Filing History:

goldMedal18 out of 130 
 
Cadila Healthcare Limited
 patents

Years Active: 2012-2019

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 10435363 - Process for preparation of pyrroles having hypolipidemic hypocholesteremic activities (2019-10-08),
2. 9879011 - Amorphous form of linagliptin and process for preparation thereof (2018-01-30),
3. 9840469 - Polymorphic forms of ivabradine hydrochloride (2017-12-12),
4. 9714225 - Processes for the preparation of lorcaserin (2017-07-25),
5. 9650344 - Polymorphic forms of ivabradine hydrochloride (2017-05-16),
6. 9439903 - Process for the preparation of amorphous imatinib mesylate (2016-09-13),
7. 9382209 - Polymorphic forms of ivabradine hydrochloride (2016-07-05),
8. 9249134 - Process for preparation of amorphous form of dasatinib (2016-02-02),
9. 9212166 - Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof (2015-12-15),
10. 9139527 - Method of preparation of pitavastatin and pharmaceutical acceptable salts thereof (2015-09-22),
11. 9120755 - Polymorphic forms of ivabradine hydrochloride (2015-09-01),
12. 9034901 - Pitavastatin calcium and process for its preparation (2015-05-19),
13. 9012678 - Processes for the preparation of fesoterodine (2015-04-21),
14. 8962851 - One-pot process for the preparation of benzimidazole derivatives (2015-02-24),
15. 8933123 - Polymorphic forms of O-desmethyl-venlafaxine succinate (2015-01-13),

Title: Inventor Spotlight: Shriprakash Dhar Dwivedi

Introduction

Shriprakash Dhar Dwivedi is an esteemed inventor based in Gujarat, India, known for his remarkable contributions to the field of pharmaceuticals. With a portfolio of 18 patents, he has significantly impacted the development of innovative therapeutic solutions.

Latest Patents

Dwivedi's latest patents include two notable inventions. The first is a "Process for Preparation of Pyrroles Having Hypolipidemic Hypocholesteremic Activities." This invention provides pyrroles that exhibit beneficial effects on lipid and cholesterol levels, featuring the pharmaceutical compound saroglitazar along with its salts, hydrates, and intermediates. The second patent, "Amorphous Form of Linagliptin and Process for Preparation Thereof," details a novel amorphous form of linagliptin and its effective use in treating diabetes, particularly type-I and type-II diabetes. This patent also discusses the preparation of a pharmaceutical composition that comprises this unique form of linagliptin.

Career Highlights

Dhar Dwivedi currently works at Cadila Healthcare Limited, a leading player in the pharmaceutical industry. His innovative mindset and dedication to research have propelled his career, allowing him to secure multiple patents that enhance health care outcomes.

Collaborations

Throughout his journey, Shriprakash Dhar Dwivedi has collaborated with talented professionals such as Ashok Prasad and Dhimant Jasubhai Patel. Their collective expertise has fostered advancements in medical research and the development of essential pharmaceutical products.

Conclusion

In conclusion, Shriprakash Dhar Dwivedi's contributions to the pharmaceutical industry through his patents on pyrroles and linagliptin showcase his commitment to innovation. His work not only enhances medical treatments but also emphasizes the importance of collaboration in scientific research. As he continues to push the boundaries of pharmaceutical advancements, his impact will undoubtedly resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…